ATE374603T1 - Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation - Google Patents

Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation

Info

Publication number
ATE374603T1
ATE374603T1 AT01995691T AT01995691T ATE374603T1 AT E374603 T1 ATE374603 T1 AT E374603T1 AT 01995691 T AT01995691 T AT 01995691T AT 01995691 T AT01995691 T AT 01995691T AT E374603 T1 ATE374603 T1 AT E374603T1
Authority
AT
Austria
Prior art keywords
peptide
lipid nanoparticles
amphiphilic lipid
protein incorporation
incorporation
Prior art date
Application number
AT01995691T
Other languages
English (en)
Inventor
Curto Maria Dorly Del
Daniela Chicco
Pierandrea Esposito
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of ATE374603T1 publication Critical patent/ATE374603T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01995691T 2000-12-27 2001-12-17 Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation ATE374603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128555 2000-12-27
EP01125742 2001-10-26

Publications (1)

Publication Number Publication Date
ATE374603T1 true ATE374603T1 (de) 2007-10-15

Family

ID=26071689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01995691T ATE374603T1 (de) 2000-12-27 2001-12-17 Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation

Country Status (15)

Country Link
US (1) US20040081688A1 (de)
EP (1) EP1345597B1 (de)
JP (1) JP4072057B2 (de)
AR (1) AR032073A1 (de)
AT (1) ATE374603T1 (de)
AU (1) AU2002226374B2 (de)
CA (1) CA2431888C (de)
CY (1) CY1106995T1 (de)
DE (1) DE60130791T2 (de)
DK (1) DK1345597T3 (de)
ES (1) ES2291379T3 (de)
IL (2) IL156531A0 (de)
PT (1) PT1345597E (de)
SI (1) SI1345597T1 (de)
WO (1) WO2002051390A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
EP1633322A2 (de) * 2003-06-04 2006-03-15 Nanobio Corporation Zusammensetzungen zur inaktivierung von pathogenen mikroorganismen, verfahren zur herstellung der zusammensetzungen und anwendungsverfahren dafür
EA200600877A1 (ru) * 2003-10-31 2006-12-29 Тева Фармасьютикал Индастриз, Лтд. Наночастицы для доставки лекарств
CA2549966A1 (en) * 2003-12-24 2005-07-07 Ltt Bio-Pharma Co., Ltd. Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
JP5368793B2 (ja) 2005-07-18 2013-12-18 ユニバーシティ オブ マサチューセッツ ロウエル ナノエマルジョンを製造および使用するための組成物および方法
EP1951200A2 (de) * 2005-08-09 2008-08-06 Nanobio Corporation Eine nanoemulsion enthaltende zusammensetzungen mit entzündungshemmender wirkung
US20090098205A1 (en) * 2005-09-15 2009-04-16 Council Of Scientife & Industrial Research pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES
PT3144013T (pt) * 2005-12-01 2019-02-07 Univ Massachusetts Lowell Nanoemulsões botulínicas
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2007106683A2 (en) * 2006-03-10 2007-09-20 The Trustees Of The University Of Pennsylvania Biomimetic iron-oxide-containing lipoprotein and related materials
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
AU2007353340A1 (en) 2006-12-01 2008-11-20 Anterios, Inc. Peptide nanoparticles and uses therefor
KR100834687B1 (ko) * 2007-02-21 2008-06-02 주식회사 엘지생활건강 히노키티올 함유 지질 나노 입자 및 그의 제조방법
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
CN101322719B (zh) * 2007-06-15 2012-03-07 杭州民生药业有限公司 一种三氧化二砷固体脂质纳米粒及其制剂
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
ES2765240T3 (es) 2008-06-16 2020-06-08 Pfizer Nanopartículas poliméricas cargadas de fármaco y procedimientos de fabricación y uso de las mismas
EA020753B1 (ru) 2008-06-16 2015-01-30 Бинд Терапьютикс, Инк. Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
US20110212157A1 (en) * 2008-06-26 2011-09-01 Anterios, Inc. Dermal delivery
WO2010068866A2 (en) 2008-12-12 2010-06-17 Bind Biosciences Therapeutic particles suitable for parenteral administration and methods of making and using same
ES2776126T3 (es) * 2008-12-15 2020-07-29 Pfizer Nanopartículas de circulación prolongada para la liberación sostenida de agentes terapéuticos
EP2266546A1 (de) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen
BR112012000826B1 (pt) 2009-07-06 2022-07-26 Variation Biotechnologies Inc Método para a preparação de vesículas
CA2803282C (en) 2009-07-06 2018-05-01 David E. Anderson Methods for preparing vesicles and formulations produced therefrom
WO2011072218A2 (en) 2009-12-11 2011-06-16 Bind Biosciences Stable formulations for lyophilizing therapeutic particles
WO2011084513A2 (en) 2009-12-15 2011-07-14 Bind Biosciences, Inc. Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
WO2012006367A2 (en) 2010-07-06 2012-01-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
KR20130100290A (ko) 2010-08-30 2013-09-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
US20130323280A1 (en) * 2011-01-13 2013-12-05 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2862864C (en) 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
US20120189677A1 (en) * 2011-01-20 2012-07-26 Stephen Tonge Formulations
DE102011116069A1 (de) 2011-10-18 2013-04-18 Dr. Rimpler Gmbh Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung
EP2802353A4 (de) 2012-01-12 2015-12-02 Variation Biotechnologies Inc Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN104244984B (zh) 2012-01-27 2020-03-31 变异生物技术公司 用于治疗剂的方法和组合物
PT2895156T (pt) 2012-09-17 2019-06-28 Pfizer Processo para a preparação de nanopartículas terapêuticas
WO2014092596A1 (ru) * 2012-12-12 2014-06-19 Vitkalova Tamara Aleksandrovna Субстанции и фармацевтические композиции на их основе для лечения заболеваний человека, в том числе, для лечения хронических вирусных гепатитов "в" и "с"
US9693958B2 (en) * 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
SI3116547T1 (sl) 2014-03-14 2019-08-30 Pfizer, Inc. Terapevtski nanodelci, ki obsegajo terapevtsko stredstvo, in postopek izdelave ter uporabe le-teh
WO2015148483A1 (en) * 2014-03-24 2015-10-01 University Of Mississippi Systems and methods for preparing solid lipid nanoparticles
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
IL267923B2 (en) * 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤
JP2020152673A (ja) 2019-03-20 2020-09-24 株式会社リコー ナノ粒子及びナノ粒子の製造方法、並びに医薬
CN111388451B (zh) * 2020-04-29 2023-05-23 南京工业大学 蛋白自组装铁基纳米粒及其制备方法与抗肿瘤药物递送系统中的应用
WO2022072348A1 (en) 2020-09-29 2022-04-07 Oxford University Innovation Limited Stroke treatment
CN113952301A (zh) * 2021-11-17 2022-01-21 胡振华 中链脂肪酸作为促吸收剂制备药物组合物乳剂的应用
DE202023100649U1 (de) 2023-02-10 2023-03-22 Cineolux Gmbh Dispersion und Zubereitung zur topischen Anwendung
DE102023103292A1 (de) 2023-02-10 2024-08-14 Cineolux Gmbh Dispersion und Zubereitung zur topischen Anwendung
WO2024259158A2 (en) * 2023-06-13 2024-12-19 Cornell University Lipid nanoparticles for peptide delivery and methods of making and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
US6967028B2 (en) * 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration

Also Published As

Publication number Publication date
EP1345597B1 (de) 2007-10-03
JP2004519447A (ja) 2004-07-02
EP1345597A2 (de) 2003-09-24
WO2002051390A2 (en) 2002-07-04
CY1106995T1 (el) 2012-09-26
DK1345597T3 (da) 2007-12-10
CA2431888C (en) 2010-06-01
US20040081688A1 (en) 2004-04-29
ES2291379T3 (es) 2008-03-01
JP4072057B2 (ja) 2008-04-02
DE60130791T2 (de) 2008-07-17
IL156531A0 (en) 2004-01-04
IL156531A (en) 2008-11-03
AR032073A1 (es) 2003-10-22
CA2431888A1 (en) 2002-07-04
PT1345597E (pt) 2007-10-29
AU2002226374B2 (en) 2006-06-08
SI1345597T1 (sl) 2007-12-31
WO2002051390A3 (en) 2002-10-10
DE60130791D1 (de) 2007-11-15

Similar Documents

Publication Publication Date Title
ATE374603T1 (de) Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation
CY2022030I1 (el) Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες
EP1636250A4 (de) Selbstorganisierendes, modifikationen enthaltende peptide und verfahren zu deren anwendung
IS2620B (is) Mennskgerð mótefni sem greina beta-amýlóíðpeptíð
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
AR027815A1 (es) Formulacion farmaceutica y metodo para su produccion
NO20021333D0 (no) Sammensetning som innbefatter kasein- og myseprotein
BR0212253B1 (pt) material e artigo para fumar.
GB2369283B (en) Incorporation of soy proteins in cheese
NO20025158D0 (no) Lipidpreparat og anvendelse derav
EP1369101A4 (de) Kosmetisches w/ö/w-emulsionspräparat
EP1622585A4 (de) Lipid-platin-komplexe und anwendungsverfahren dafür
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60117622D1 (de) Produkte zur nagelpflege
DE60111459D1 (de) Zubereitungen zur transdermalen verabreichung hydrophiler substanzen
ATA6742001A (de) Verfahren und einrichtung zur bestimmung des weiblichen hormonstatus
AU2001276798A1 (en) Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis
EP1581250A4 (de) Orale formulierungen für proteine und polypeptide
EP1337543A4 (de) Streptavidin-bindende peptide und deren verwendung
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
FI20030315A0 (fi) Menetelmiä ja konstruktioita valikoitujen aminohappojen pitoisuuksien lisäämiseksi siemenissä
PL1693378T3 (pl) Białko NMB1125 i jego zastosowanie w kompozycjach farmaceutycznych
GB0000540D0 (en) Protein and/or peptide based artificial saliva

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1345597

Country of ref document: EP